These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33216887)

  • 1. Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipients.
    Nelson AS; Heyenbruch D; Rubinstein JD; Sabulski A; Jodele S; Thomas S; Lutzko C; Zhu X; Leemhuis T; Cancelas JA; Keller M; Bollard CM; Hanley PJ; Davies SM; Grimley MS
    Blood Adv; 2020 Nov; 4(22):5745-5754. PubMed ID: 33216887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Generation of BK polyomavirus-specific T cells for adoptive cell therapy in refractory cystitis hemorrhagic patients after hematopoietic stem cell transplantation.
    Najafabadi MM; Soleimani M; Ahmadvand M; Zomorrod MS; Mousavi SA
    BMC Immunol; 2022 Jun; 23(1):31. PubMed ID: 35689183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third-Party and Patient-Specific Donor-Derived Virus-Specific T Cells Demonstrate Similar Efficacy and Safety for Management of Viral Infections after Hematopoietic Stem Cell Transplantation in Children and Young Adults.
    Galletta TJ; Lane A; Lutzko C; Leemhuis T; Cancelas JA; Khoury R; Wang YM; Hanley PJ; Keller MD; Bollard CM; Davies SM; Grimley MS; Rubinstein JD
    Transplant Cell Ther; 2023 May; 29(5):305-310. PubMed ID: 36736781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients.
    Abudayyeh A; Hamdi A; Abdelrahim M; Lin H; Page VD; Rondon G; Andersson BS; Afrough A; Martinez CS; Tarrand JJ; Kontoyiannis DP; Marin D; Gaber AO; Oran B; Chemaly RF; Ahmed S; Abudayyeh I; Olson A; Jones R; Popat U; Champlin RE; Shpall EJ; Rezvani K
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27862740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of BK polyomavirus viremia on the outcomes of allogeneic hematopoietic stem cell transplantation.
    Umezawa Y; Yoshifuji K; Tanaka K; Nogami A; Nagano K; Tsuji A; Nagao T; Yamamoto M; Kajiwara M; Tohda S; Mori T
    Ann Hematol; 2024 May; 103(5):1737-1744. PubMed ID: 38509389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients.
    Rubinstein JD; Jodele S; Heyenbruch D; Wilhelm J; Thomas S; Lutzko C; Zhu X; Leemhuis T; Cancelas JA; Keller M; Bollard CM; Hanley PJ; Boghdadly ZE; Mims A; Davies SM; Grimley MS; Nelson AS
    Transplant Cell Ther; 2022 Feb; 28(2):116.e1-116.e7. PubMed ID: 34785398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
    Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
    Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful BK virus-specific T cell therapy in a kidney transplant recipient with progressive multifocal leukoencephalopathy.
    Sempere A; Castillo N; Rudilla F; Querol S; Enrich E; Prat-Vidal C; Codinach M; Cofan F; Torregrossa V; Dieckmann F; Bodro M
    Am J Transplant; 2024 Sep; 24(9):1698-1702. PubMed ID: 38734417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in virus-specific T-cell therapy for polyomavirus infections: A comprehensive review.
    Alkan B; Tuncer MA; İnkaya AÇ
    Int J Antimicrob Agents; 2024 Nov; 64(5):107333. PubMed ID: 39245328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2020 Apr; 35(4):625-631. PubMed ID: 31858227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse gastrointestinal bleeding and BK polyomavirus replication in a pediatric allogeneic haematopoietic stem cell transplant patient.
    Koskenvuo M; Lautenschlager I; Kardas P; Auvinen E; Mannonen L; Huttunen P; Taskinen M; Vettenranta K; Hirsch HH
    J Clin Virol; 2015 Jan; 62():72-4. PubMed ID: 25542476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
    Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
    BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BK polyomavirus infection: more than 50 years and still a threat to kidney transplant recipients.
    Parajuli S; Aziz F; Zhong W; Djamali A
    Front Transplant; 2024; 3():1309927. PubMed ID: 38993764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hemorrhagic cystitis caused by the BK polyomavirus is associated with decreased survival post-allogeneic hematopoietic stem cell transplantation.
    Kerbauy LN; Kerbauy MN; Bautzer V; Chapchap EC; de Mattos VRP; da Rocha JDA; Esteves I; Kutner JM; Kerbauy FR; Ribeiro AAF; Machado CM; Hamerschlak N; Santos FPS
    Transpl Infect Dis; 2019 Oct; 21(5):e13101. PubMed ID: 31054192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
    El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
    Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal BK polyomavirus-associated pneumonia: report of two cases with literature review.
    Wang Y; Fang Y; Yan Z; Xia R; Zeng W; Deng W; Xu J; Feng X; Peng J; Miao Y
    BMC Infect Dis; 2023 Sep; 23(1):592. PubMed ID: 37697264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant.
    Khoury R; Grimley MS; Nelson AS; Leemhuis T; Cancelas JA; Cook E; Wang Y; Heyenbruch D; Bollard CM; Keller MD; Hanley PJ; Lutzko C; Pham G; Davies SM; Rubinstein JD
    Am J Transplant; 2024 Sep; 24(9):1634-1643. PubMed ID: 38643944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of HPyV9 and TSPyV coinfection on the development of BK polyomavirus viremia and associated nephropathy after kidney transplantation.
    van Rijn AL; Wunderink HF; de Brouwer CS; van der Meijden E; Rotmans JI; Feltkamp MCW
    J Med Virol; 2019 Jun; 91(6):1142-1147. PubMed ID: 30624811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antibodies against BKPyV subtype I and IV in kidney transplant recipients and in the general Czech population.
    Hejtmánková A; Roubalová K; Forejtová A; Žáčková Suchanová J; Forstová J; Viklický O; Španielová H
    J Med Virol; 2019 May; 91(5):856-864. PubMed ID: 30609063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BK polyomavirus in kidney transplant recipients: screening, monitoring and clinical management.
    Varella RB; Almeida JR; Lopes Pde F; Matos JP; Menezes P; Lugon JR
    J Bras Nefrol; 2014; 36(4):529-34. PubMed ID: 25517283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.